Sunday, February 28, 2010

Interview Questions for Prof. Slavin

1.) How long have you been practicing medicine?

2.) What field of medicine do you practice in and why did you choose to practice in this field?

3.) You're work with cell therapy is groundbreaking and helping so many people, when did you begin working with/developing cell therapies and why?

4.) How much research and schooling did you need to have before you were prepared to develop your first cell therapy?

5.) Was a cell therapy a fairly new concept when you began working with cell therapy of cancer by donor lyphocyte infucions, post allogeneic stem cell transplantation, and nonmyeloablative stem cell transplantation?

6.) I'm unfamiliar with these treatments, what is the most common disease that each treats and how what are the steps of each treatment?

7.) Do you specialize in any type of stem cell therapy? If so, what kind and who are the typical canidates to recieve this therapy?

8.) On average, how many patients does CTCI treat each year?

9.) Have you ever used human embryonic stem cells for a cell therapy? If so, what was the therapy treating?

10.) What is one of your most memorable cases that you've had as a doctor? How was it treated, and was the treatment a success?

11.) Your website says that CTCI is the Internation Center for Cell Therapy and Cancer Immunotherapy, can you explain to me what Cancer Immunotherapy is?

12.) How long did it take for your therapies to be used worldwide?

Thursday, February 25, 2010

Response: Stem Cell Approvals 15

I think it's terrific that the FDA and NIH are making an effort to get breakthroughs such as stem cell therapies out and available to the public. The article did not mention any kind of stem cells in particular, so I'm curious as to which type they were referring to. Stem cells in general? Adult stem cells? Human embryonic?

This particular article didn't even brush on the ethical controversy of stem cell therapies. It was more focused on the politics of the situation with the FDA and new breakthroughs in general. I was pleased to find out that stem cells will be one of the focuses in developing breakthroughs.

I hope to hear more soon about which areas are awarded the grant money and if stem cell therapy development will receive any of the $6.75 million. In a previous article, California received grants specifically aimed to benefit stem cell research, both adult and embryonic.

For the FDA to be making this kind of contribution is exciting. Stem cell therapies are a very up and coming procedure and hopefully will not be over looked when the grants are awarded to avoid controversy.

Notes: Stem Cell Approvals 15

• Stem cell therapies are a medical treatment that US officials (FDA) is very interested in further evaluating.

• February 24, 2010 in an effort by the FDA and National Institute of Health (NIH) 6.75 million dollars are being made available in grants for the progression of medical research, specifically turning potential treatments into options available to the public.

• Health and Human Services Secretary, Kathleen Sebelius says "We want to accelerate and illuminate the pathway from microscope to market," something that would be incredibly influential to make stem cell therapies available in the US. "For Americans this is going to mean that new treatments are safer and available sooner."

• President Obama proposed a $4.03 billion budget to the FDA for the fiscal year.

• A new panel is being made to evaluate new leaps and discoveries for the FDA and will include 6 senior scientists from a collaboration of agencies.

Friday, February 19, 2010

Parent comment

BLOG COMMENT

MY NAME as author of the blog: Emily Whitaker
TITLE OF MY BLOG: New and Developing Stem Cell Research
NAME OF PERSON WITH WHOM I SHARED MY BLOG: Colleen Whitaker
RELATIONSHIP OF PERSON TO ME: Mom
DATE I SHARED MY BLOG: February 18, 2010

COMMENTS FROM RELATIVE WHO LISTENED TO MY EXPLANATION AND READ MY BLOG:

After reading the blog entry in it’s entirety, I can say how interesting it was to watch the authors knowledge and opinions grow and change as the writings progressed. I felt as if even though I, as learning about the vast subject of stem cell research and all it entails, the author was also learning right along with me. Her personal progression was just as interesting as the blog itself. The topic is fascinating and could and may potentially affect all of us in one way or another in our lifetime.

The interview was the most impressive of all the aspects of the blog. It gave the blog a personal approach not just a researchers perspective or interested party but a human element.

Emily’s blog was educational, informative and interesting. I wanted to read more when I was finished with her final entry. That is a sure sign of a solid topic and skilled writer. The only errors I found were it was hard to read with the changes to the font. I also found some minor spelling errors but they were minimal considering the length and number of entries in the blog. She clearly feels passionate about this topic and that took over which perhaps lead to the errors. I found that most errors mentioned were corrected, like the consistency of the font, in her newer entries.

Perhaps one suggestion I have for Emily is to give definitions to words or medical terms used immediately in the blog when used, maybe within parenthesis directly following the term or word.

C.Whitaker


Sunday, February 7, 2010

Response: Ardnt Roehlig interview 2. 14

I was so pleased to have the opportunity to interview Arndt Roehlig again. It's been nearly a year since he received his stem cell therapy in Istanbul, and he's already looking forward to a new generation of treatment from Dr. Slavin. As a part of the interview, Roehlig gave me Dr. Slavin's e-mail address. I'm looking forward to hopefully having the chance to interview him as well.

I think it's very interesting that Dr. Slavin has already developed a new generation of stem cell therapy and it's already going through regulations and such in Istanbul as well as Athens.

I highly appreciate the insight Arndt Roehlig's given me from his first hand knowledge of stem cell therapy. I wasn't sure what to expect when I asked his opinion on hESCs. Everyone has their own opinion, and the two opinion's I've found are two different extremes.

Arndt Roehlig said that he thinks if hESCs are going to help someone who's sick, that they should use them. Although Roehlig himself has not received hESCs therapy, I'm sure he's very aware of the clashing ethical opinions. On one side you have 'help the already living" and on the other you have "don't destroy what could have been a person." I'm still slightly conflicted, but I'm leaning more toward the use of hESCs now that I have more research.

Notes: Ardnt Roehlig interview 2. 14

1. What kind of stem cell therapy did you receive? Bone marrow derived mesenchymal stromal cells (MSC)


2. Who is Dr.Slavin? Which of his quotes helped you reach your decision to receive your treatment? "The secret is to do the treatment of choice in the early stages of the disease before irreversible changes occur,"


http://www.ctv.ca/servlet/ArticleNews/story/CTVNews/20081116/ms_treatment_081116/20081116/

Shimon Slavin, M.D.
Professor of Medicine
Scientific & Medical Director
The International Center for Cell Therapy & Cancer
Immunotherapy (CTCI)
Top
Ichilov at the Weizman Center,
Tel
Aviv Medical Complex
14
Weizman Street
Tel
Aviv 64239, ISRAEL
slavin@CTCIcenter.com


3. Are you opposed to human embryonic stem cell (hESC) research? What is your opinion of hESCs? If it helps the patient, absolutely not. If you are sick and it will help you, then you should be able to receive treatment. This is a political question, as soon as the person who is against this needs this kind of help, all of the sudden they are for it and try to find a way to jump the line to be first.


4. Have you noticed a difference in your condition since the last interview? My condition is up and down, but from 100% of the speed of progression prior to infusion, I believe I’m now somewhere at 10-20% of that speed of progression.


5. How long ago did you receive your stem cell therapy in Istanbul? March 6, 2009.


6. You mentioned trying the next generation of Dr.Slavin's treatment, what will this entail? Will you have to go back to Istanbul? What are the differences between the new generation treatment and the treatment you received? When will you be able to receive this treatment? This treatment will target even more cell growth, but is in testing and approval stage with the Israeli government at this time, so not yet available. Istanbul or Athens. It is not known yet, as Dr. Slavin has told me to wait a full year to asses the progression of my disease.


7. Why did you agree to have your story posted on scienceblog.com? If I’m going to be a guinea pig, I might as well share my experience.


8. How has this treatment effected your daily life? I am grateful for it as I still have some ability as compared to where I would have been with out treatment.


9. Is there anything else you would like to add about your personal opinions/experiences regarding stem cell treatments? I think we are on the cusp of finding something successful.


Thursday, February 4, 2010

Excellent research!

I am fascinated by what you are finding because of your willingness to put a solid effort into your research. Your information about the xcell website and the work that is being done in Germany is eye-opening. Even Alzheimer's responding to stem cell therapy - amazing! Keep up the outstanding work . . . !

Wednesday, February 3, 2010

Response: difference between adult stem cells and hESCs 13

This article was the perfect background information I had been looking for. There were basic pros and cons of hESCs and adult stem cells, as well as clearly stated differences. I am aware that these pros, cons, and differences might be altered since the article was written months ago. However, it was an excellent base to help me see the distinct differences between hESCs and adult stem cells.

I found it interesting that scientists were expecting that hESCs were more likely to be rejected during transplant than adult stem cells. This does make sense though, adult stem cells come from one's own body, where as hESCs are foreign.

Also, I had never read anywhere else that adult stem cells are rare. I was under the assumption that they were everywhere! As it turns out, they are more difficult to find and harder to culture than hESCs. I also didn't know that adult stem cells can only be cultured into more of the original tissue that they were taken from. Where as hESCs can be cultured into any type of cell.

I'm pleased to have found this information, but still wary, it might not all be completely accurate. For example, they said hESCs were more likely to be rejected from the body, but hESCs also don't produce tumors like adult stem cells do.

Notes: difference between adult stem cells and hESCs 13

hESCs can be easily cultured, adult stem cells are rare and more limited

hESCs are pluripotent and can become any type of cell, adult stem cells can only be cultured into more of their original tissues

hESCs are easy to culture, adult stem cells are challenging to find in mature tissues

number of cells you can culture through adult stem cells are still limited. This is a challenge because mass amounts of cells are needed for stem cell therapies.

scientists are curious to see if hESCs will be rejected less during transplant than adult stem cells. they will be able to know after clinical trails are more developed since they have only recently been approved the the United State's FDA.